US2020123110A1PendingUtilityA1
Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
Est. expirySep 25, 2021(expired)· nominal 20-yr term from priority
Inventors:Takuji BandoSatoshi AokiJunichi KawasakiMakoto IshigamiYouichi TaniguchiTsuyoshi YabuuchiKiyoshi FujimotoYoshihiro NishiokaNoriyuki KobayashiTsutomu FujimuraMasanori TakahashiKaoru AbeTomonori NakagawaKoichi ShinhamaNaoto UtsumiMichiaki TominagaYoshihiro OoiShohei YamadaKenji Tomikawa
A61P 25/24C07D 215/22A61K 9/2018A61K 9/1652A61P 25/20A61K 9/2013A61K 31/496C07D 215/227Y10T428/2982C07B 2200/13A61P 25/00A61P 25/06A61P 25/18A61P 25/22A61P 1/08A61P 25/28A61P 25/04A61P 3/04A61P 15/10A61P 25/16A61K 9/2059A61P 25/32A61P 15/00A61P 25/30
76
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides low hygroscopic forms of aripiprazole and processes for the preparation thereof which will not convert to a hydrate or lose their original solubility even when a medicinal preparation containing the anhydrous aripiprazole crystals is stored for an extended period.
Claims
exact text as granted — not AI-modified1 . Hydrate A of aripiprazole having a powder x-ray diffraction spectrum comprising characteristic peaks at 2θ=12.6°, 15.4°, 17.3°, 18.0°, 18.6°, 22.5°, and 24.8° using a Cu K α x-ray.
Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.